- Home
- MRKR vs ELBM Comparison
MRKR vs ELBM Comparison
Compare MRKR & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- ELBM
- Stock Information
- Founded
- MRKR N/A
- ELBM 2011
- Country
- MRKR United States
- ELBM Canada
- Employees
- MRKR N/A
- ELBM N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- ELBM Industrial Machinery/Components
- Sector
- MRKR Health Care
- ELBM Miscellaneous
- Exchange
- MRKR Nasdaq
- ELBM Nasdaq
- Market Cap
- MRKR 19.1M
- ELBM 18.5M
- IPO Year
- MRKR N/A
- ELBM N/A
- Fundamental
- Price
- MRKR $1.47
- ELBM $1.09
- Analyst Decision
- MRKR Strong Buy
- ELBM Strong Buy
- Analyst Count
- MRKR 3
- ELBM 1
- Target Price
- MRKR $13.17
- ELBM $2.20
- AVG Volume (30 Days)
- MRKR 231.4K
- ELBM 701.7K
- Earning Date
- MRKR 08-13-2025
- ELBM 08-13-2025
- Dividend Yield
- MRKR N/A
- ELBM N/A
- EPS Growth
- MRKR N/A
- ELBM N/A
- EPS
- MRKR N/A
- ELBM N/A
- Revenue
- MRKR $5,696,123.00
- ELBM N/A
- Revenue This Year
- MRKR N/A
- ELBM N/A
- Revenue Next Year
- MRKR $11.28
- ELBM N/A
- P/E Ratio
- MRKR N/A
- ELBM N/A
- Revenue Growth
- MRKR 71.53
- ELBM N/A
- 52 Week Low
- MRKR $0.95
- ELBM $0.91
- 52 Week High
- MRKR $5.99
- ELBM $2.83
- Technical
- Relative Strength Index (RSI)
- MRKR 50.81
- ELBM 54.48
- Support Level
- MRKR $1.41
- ELBM $1.06
- Resistance Level
- MRKR $1.53
- ELBM $1.15
- Average True Range (ATR)
- MRKR 0.16
- ELBM 0.07
- MACD
- MRKR -0.03
- ELBM 0.00
- Stochastic Oscillator
- MRKR 9.43
- ELBM 29.63
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.